Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

DuPont Sues SunEdison For Patent Infringement

RELATED NEWS
Trade DD now with 

E. I. du Pont de Nemours and Co. (DD: Quote) said Thursday that it has filed a patent infringement lawsuit against SunEdison and its affiliate NVT LLC in the U.S. District Court for the District of Delaware.

In its complaint, DuPont alleges that by sourcing and using photovoltaic cells and solar modules containing Samsung SDI Co., Ltd. front side metallization paste, SunEdison infringes DuPont's patented tellurium paste technology. The complaint also identifies Neo Solar Power of Taiwan as the cell manufacturer and Flextronics International Ltd. (FLEX) as SunEdison's contract manufacturer.

Click here to receive FREE breaking news email alerts for EI DuPont De Nemours & Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Monday, extending the strong upward move seen last Friday. The gains on the day continued the recent recovery by the markets, with the Nasdaq and the S&P 500 closing higher for the third consecutive session. While Republicans have largely tried to frame the upcoming midterm elections as a referendum on President Barack Obama, Sen. Ted Cruz, R-Tex., has joined the few offering guidance on what the GOP will do if it manages to retake control of the Senate. The World Health Organization (WHO) Monday declared that Nigeria is officially free of Ebola virus transmission. For the last six weeks, no new cases of the deadly virus infection has been reported in the country. The lines on the tabular situation reports, sent to WHO each day by its country office in Nigeria, have now been full of zeros for 42 days. If two incubation periods of 21 days pass
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.